🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

20 recruiting trials

for Human Papillomavirus Vaccination

Provider Recommendation and HPV Vaccination NCT05365048NA1 site📍 Pasadena Kaiser Permanente · Tests: Local Tailoring implementation strategy, Prescribed Strategy Multiple Human Papillomavirus Infections in the Development of CIN NCT06862102n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia · Tests: HPV vaccine Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine NCT05371353n/a2 sites📍 Yangchun📍 Mianyang Shanghai Bovax Biotechnology Co., Ltd. Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination NCT07407569Phase 23 sites📍 Antwerp📍 Ghent📍 Leuven Universiteit Antwerpen · Tests: Gardasil 9 (2 dose regimen) Stories to Prevent (StoP) HPV Cancers NCT06808776NA1 site📍 Hershey Milton S. Hershey Medical Center · Tests: Cancer survivor narrative, Healthy eating tips A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV NCT05495906Phase 410 sites📍 Surrey📍 Vancouver📍 Winnipeg University of British Columbia · Tests: Nonavalent HPV vaccine HPV-based Screening Among Women 23-29 Years of Age NCT05229679NA2 sites📍 Lund📍 Stockholm Karolinska Institutet · Tests: HPV testing Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) NCT05672927Phase 41 site📍 Galveston The University of Texas Medical Branch, Galveston · Tests: 9-valent HPV vaccine, 2 doses alternate timing, 9-valent HPV vaccine, 3 doses standard timing Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI NCT07301905NA1 site📍 Flint Michigan State University · Tests: General HPV Vaccine Health Messaging, Culturally Targeted HPV Vaccine Health Messaging Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts NCT05625633Phase 2, Phase 32 sites📍 Salt Lake City📍 Salt Lake City Western Institute for Veterans Research · Tests: Human Papillomavirus 9-valent Vaccine, Recombinant, Normal Saline Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial NCT06926062NA2 sites📍 University Park📍 Seattle Fred Hutchinson Cancer Center · Tests: Best Practice, Educational Intervention, Educational Intervention, Educational Intervention, Educational Intervention A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial NCT07104240NA1 site📍 Atlanta Emory University · Tests: Best Practice, Educational Intervention, Health Promotion and Education, Health Promotion and Education, Internet-Based… The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Health Beliefs, and Vaccination Behavior Intentions NCT07248904NA2 sites📍 Adana📍 Adana Cukurova University · Tests: TTM-Based Educational Program Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents NCT06598475NA1 site📍 Houston The University of Texas Health Science Center, Houston · Tests: Facilitator-driven provider- and practice-level implementation strategies for influencing provider recommendations and … A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV) NCT05334706Phase 41 site📍 L'Hospitalet de Llobregat Miquel Angel Pavon Ribas · Tests: Nonavalent HPV vaccine (9vHPV/Gardasil-9™). Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation NCT06793410Phase 25 sites📍 Lund📍 Stockholm📍 Uppsala Vastra Gotaland Region · Tests: Early start post-transplant vaccination with Gardasil 9®, Late post-transplant vaccination with Gardasil 9® Active Health Education to Increase HPV Vaccine Coverage in Youth: A Stepped-wedge, Cluster, and Randomized Trial NCT06513494NA79 sites📍 Crato📍 Crato📍 Crato Hospital Israelita Albert Einstein · Tests: Active Students Education plus Teacher Training, Active Students Education, Basic Health Unit Active Orientation, Usual… Strengthening HPV Immunization Through EPI Leveraged Delivery NCT07377656Phase 21 site📍 Accra International Vaccine Institute · Tests: HPV vaccine, Placebo, Measles and rubella Vaccine Characteristics of Human Papillomavirus (HPV) Infections and HPV Vaccine Attitudes Among Slovenian Women After the Introduction of HPV Vaccination NCT06995157NA1 site📍 Ljubljana University Medical Centre Ljubljana · Tests: Offering HPV vaccine The STOP-HPV Scale Up Study NCT06831383NA1 site📍 Alexandria University of California, Los Angeles · Tests: STOP-HPV-Online, STOP-HPV-LC
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy